drugset / Trial / NCT00091286
Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines made from peptides may make the body build an immune response to kill tumor cells. PURPOSE: This clinical trial is studying how well vaccine therapy works in treating patients with stage IIB, stage III, or stage IV colorectal cancer.
Timeline
- Start
- 2003-03-24
- Primary completion
- 2008-02-15
- Completion
- 2008-02-15
Outcome
Outcome not reported
Stopped (Enrollment): “Slow accruals”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CEA peptides | Unknown | 100 ug | — |
| Subject | HER-2-neu | Unknown | 100 ug | — |
| Background | incomplete Freund's adjuvant | Other / unclassified | — | — |
| Background | sargramostim | Protein / enzyme biologic | 110 ug | — |